Browse > Article

THE EXPERIMENTAL STUDY ON BONE HEALING AROUND TITANIUM IMPLANTS PLACED IN IRRADIATED RAT'S TIBIAE  

Kwak, Byung-Hak (Oral & Maxillofacial Surgery, Oral Anatomy, Pusan National University)
Kim, Jong-Ryoul (Oral & Maxillofacial Surgery, Oral Anatomy, Pusan National University)
Park, Bong-Soo (College of Dentistry, Pusan National University)
Shin, Sang-Hoon (Oral & Maxillofacial Surgery, Oral Anatomy, Pusan National University)
Sung, Iel-Yong (Oral & Maxillofacial Surgery, College of Medicine, Ulsan University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.29, no.6, 2003 , pp. 379-391 More about this Journal
Abstract
The present study was undertaken to evaluate bone regenerative capacity around titanium screw implants placed in irradiated rat's tibiae. At one week after single 15-Gy dose irradiation, miniaturized titanium screw implants were inserted into anterior aspect of the upper tibia of rats weighing 200-250g. Seventy rats were involved: 35 rats were control and 35 rats radiation group. The rats were killed at different intervals as 1, 2, 3, 4, 6, 8, 12 weeks after implantation for histologic observation, histomorphometric analysis and immunohistochemical study with fibronectin and CD34 antibody. 1. Histologically, various stages of bone maturation and ossification can be seen at 4 weeks and regenerated bone close to edges demonstrates more advanced calcification, and network of new bone are well formed at 12 weeks in non-irradiated group. In contrast, active bone formation with increased contact of newly formed bone to implant surface was noted at 4 weeks and a significant amount of new bone formation and bone-implant contact is oberved at 12 weeks in irradiated group. 2. Histomorphometrical analysis confirmed these histologic findings. A significant difference in implant-bone contact and bone density was measured between the control and radiation group. Mean MBD was 62.2% in control group and 27.5% in radiation group, mean MBIC was 86.6% in control group and 47.7% in radiation group, and mean TBIC was 87.3% in control group and 45.6% in radiation group at 12 weeks after implantation. 3. In immunohistochemical study with fibronectin and CD34, radiation reduced hematopoietic progenitor cells severely and disturbed differentiation of osteoblast in bone marrow. The results of this study revealed bone healing capacity around implant after radiation therapy was severely impaired and irradiation reduces the capacity for osseointegration of titanium implants. Many factors including radiation dose, period between radiation and implantation, bone quality, time elapse between first and second surgery, type of prosthetics and hyperbaric oxygen therapy must be considered carefully in postradiation implantation.
Keywords
Implant; Immunohistochemistry; Histomorphometry;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Franzen L, Rosenquist JB, Orsenquist KI, Gustafsson I: Oral implants rehabillitation of patient with oral malignancies treated with radiotherapy and surgery without adjunctive hyperbaric oxygen. Int J Oral Maxillofac Implants 10:183-187, 1995.   PUBMED
2 Roumamas E, Nishimura R, Beumer J, Moy P, Weinlander M, Lorant J: Craniofacial defects and osseointegrated implants: Six-year followup report on the success rates of craniofacial implants at UCLA. Int J Oral Maxillofac Implants 64:579-585, 1994.
3 Wolfaardt JF, Wilkes GH, Parel S, Tjellstrom A: Craniofacial osseointegration: The Canadian experience. Int J Oral Maxillofac Implants 8:197-204, 1993.   PUBMED
4 Elkind MM, Sutton H: Radiation response of mammalian cells growth in culture: 1. Repair of X-ray damage surviving Chinese hamster cells. Radiat Res 13:556-593, 1960.   DOI   ScienceOn
5 Niimi A, Ueda M, Keller EE, Worthington P: Experience with osseointegrated implants in irradiated tissues in Japan and the United States. Int J Oral Maxillofac Implants 13:407-411, 1998.   PUBMED
6 Parel S, Tjellstrom A: The United States and Swedish experience with osseointegration and facial prosthesis. Int J Oral Maxillofac Implants 6:75-79, 1991.   PUBMED
7 Holyoake T, Alcorn M: CD34+ positive haemopoietic cells: biology and clinical applications. Blood Rev 8:113-124, 1994.   DOI   ScienceOn
8 Sutherland D, Stewart A, Keating A: CD34 antigen; molecular features and potential clinical applications. Stem Cells 3:50-57, 1993.
9 Moursi A, Damsky C, Lull J, Zimmerman D, Doty S, Aota S, Globus R: Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 109:1369-380, 1996.   PUBMED
10 Jisander S, Grenthe B, Alberius P: Dental implant survival in the irradiated jaw: a preliminary report. Int J Oral Maxillofac Implants 12:643-648, 1997.   PUBMED
11 Mackova N, Praslicka M: Recovery of hematopoiesis in bone marrow of mice after continuous irradiation with dose rate 4.8Gy/day. Neoplasma 28:79-89, 1981.
12 Sutherland D, Keating A: The CD34 antigen: structure, biology, and potential clinical applications. J Hematother 1:115-129, 1992.   DOI   PUBMED   ScienceOn
13 Weischer T, Mohr C: Ten-year experience in oral implant rehabilitation of cancer patients: treatment concept and proposed criteria for success. Int J Oral Maxillofac Implants 14:521-528, 1999.   PUBMED
14 Marx RE, Johnson RP: Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oal Surg Oral Med Oral Pathol 64:379-390, 1987.   DOI   ScienceOn
15 Nakai H, Niimi A, Ueda M: Histologic evaluation of clinically successful osseointegrated implants retrieved from irradiated bone : a report of 2 patients. Int J Oral Maxillofac Implants 14:442-446, 1999.   PUBMED
16 Eckert SE, Desjardine RP, Keller EE, Tolman DE: Endosseous implants in an irradiated tissue bed. J Prosthet Dent 76:45-49, 1996.   DOI   ScienceOn
17 Beumer J, Roumanas E, Nishimura R: Advances in osseointegrated implants for dental and facial rehabilitation following major head and neck surgery. Semin Surg Oncol 11:200-207, 1995.   DOI   ScienceOn
18 Marx RE: A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 41:351-357, 1983.   DOI   PUBMED
19 Globus R, Doty S, Lull J, Holmuhamedov E, Humphries M, Damsky C: Fibronectin is a survival factor for differentiated osteoblast. J Cell Sci 111:1385- 1393, 1998.   PUBMED
20 Marx RE: Osteoradionecrosis : A new concept of its pathophysiology. J Oral Maxillofac Surg 41;283-288, 1983.
21 Esser E, Wagner W: Detnal implants following radical oral cancer surgery and adjuvant radiotherapy. Int J Oral Maxillofac Implants 12:552-557, 1997.   PUBMED
22 Werkmeister R, Szulczewski D, Walteros-Benz P, Joos U: Rehabilitation with dental implants of oral cancer patients. J Craniomaxillofac Surg 27:38-41, 1999.   DOI   PUBMED   ScienceOn
23 Granstrom G, Tjellstrom A, Branemark P, Fornander J: Boneanchored recons- truction of the irradiated head and neck cancer patient Otolaryngol Head Neck Surg 108:334-343, 1993.
24 Brogniez V, D’hoore W, Gregoire V, Munting E, Reychler H: Implants placed in an irradiated dog mandible: a morphometric analysis. Int J Oral Maxillofac Implants 15:511-518, 2000.   PUBMED
25 Keller EE, Tolman DE, Zuck SL, Echert SE: Mandibular endosseous implants and autogenous bone grafting in irradiated tissue: a 10-year retrospective study. Int J Oral Maxillofac Implants 12:800-813, 1997.   PUBMED
26 Basker H, Power MP: The transmandibular reconstruction system. In Fonseca RJ, Davis WH (eds): Reconstructive preprosthetic oral and maxillofacial surgery, 2nd ed. Philadelphia, WB Saunders Co., 1995, pp 649-653.
27 Walzinger F, Ewers R, Sudasch G, Babka A: Endosteal implants in the irradiated lower jaw. J Craniomaxillofac Surg 24:237-244, 1996.   DOI   PUBMED   ScienceOn
28 Silvestri F, Banavali S, Baccarani M, Preisler H: The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications. Haematologica 77:265- 273,1992.
29 Waechter R, Stoll P: Moegichkeiten und Grezen enossaler Implantate bei der oraien Rehabilitation von Tumorpatienten nach Bestrahlung. Implantol 10:171- 176, 1994.
30 Jacobsson M, Tjellstrom A, Albrektsson T, Thomsen P, Tursson I: Integration of titanium implants in irradiated bone. Histological and clinical study. Ann Otol Rhinol Laryngol 97:337-340, 1988.   DOI   PUBMED
31 Ruoslahti E: Fibronectin. J Oral Pathol 10:3-13, 1981.   DOI   PUBMED
32 Ali A, Patton DW, Sharkawi AM, Davies J: Implant rehabilitation of irradiated jaws: a preliminary report. Int J Oral Maxillofac Implants 12:523-526, 1997.   PUBMED
33 Marx RE, Johnson RP, Kline SN: Prevention of osteoradionecrosis: A randomized prospective clinical trial of hyperbaric oxygen vs penicillin. J Am Dent Assoc 111:49-54, 1985.   DOI   PUBMED
34 Brogniez V, Lejuste P, Pecheur A, Reychler H: Dental prosthetic reconstruction of osseointegrated implants placed in irradiated bone. Int J Oral Maxillofac Implants 13:506-512, 1998.